Labcyte Inc. Commends Early Success Of Collaborator, The Institute For Molecular Medicine Finland, For Personalized Leukemia Treatment Method
Published: Dec 17, 2013
SUNNYVALE, Calif. & HELSINKI--(BUSINESS WIRE)--Just eight months after announcing a collaboration between Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM), the partnership has already led to a groundbreaking method for personalized treatment of patients with adult acute myeloid leukemia (AML).
Help employers find you! Check out all the jobs and post your resume.